This compound is a modified nucleoside derivative used as a pharmaceutical intermediate in the synthesis of nucleoside analogs. It features a benzoyl-protected amino group and a methyl substituent on the cytosine ring, along with a deoxyribose sugar moiety.
نطاق المحتوى: تتعلق المعلومات الواردة في هذه الصفحة بتحديد المواد الكيميائية وبسياقات التوريد الصناعي والبحث والإنتاج. وهي لا تشكّل ادعاءً علاجياً أو نصيحة طبية أو إرشادات لاستخدام الأدوية.
هل تشتري أو تورد هذا المركب؟
أضف مخزونك أو أنشر طلب شراء
CAS 104579-02-4
5'-O-DMT-2'-O-TBDMS-Pseudouridine
Pharmaceutical intermediate for nucleoside synthesis
N-Acetyl-5'-o-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroCytidine
Pharmaceutical intermediate for nucleoside synthesis
1,2,3,5-Tetraacetyl-beta-D-ribofuranose
Pharmaceutical intermediate for nucleoside synthesis
1,2-O-(1-methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-L-Lyxofuranose
Pharmaceutical intermediate for nucleoside synthesis
N-Benzoyl-5'-O-(bis(4-methoxyphenyl)phenylmethyl)-2'-deoxy-5-methylcytidine
Nucleoside intermediate for oligonucleotide synthesis
2-Hydroxy-3-methoxy-3,3-diphenylpropanoic Acid-d3 Methyl Ester
Pharmaceutical intermediate for ambrisentan impurities
2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole
Pharmaceutical intermediate for synthetic routes
N-(2-Amino-4,5,6,7-tetrahydro-6-benzothiazolyl)acetamide
Pharmaceutical intermediate for drug synthesis
N-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
VYJDMDIVDHHLGK-BFHYXJOUSA-N
CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)[C@H]3C[C@@H]([C@H](O3)CO)O
—